The PD-STAT/Simvastatin study results

The PD-STAT/Simvastatin study results
In 2012, an international committee of Parkinson's experts brought together by the Cure Parkinson's Trust prioritised the simvastatin for clinical evaluation in Parkinson's. The International Linked Clinical Trials (iLCT) committee believed that there was considerable supporting evidence indicating that this widely used medication may be neuroprotective and could have disease modifying potential in Parkinson's. And since that meeting, more supporting ... read more
Source: The Cure Parkinson’s TrustPublished on 2020-09-15